Spencer Ross
Growth, special situations, long only

The (CardioNet) Beat Goes On

CardioNet (NASDAQ:BEAT), which provides cardiac monitoring, manufacturing, and lab services, has just announced what may prove to be a significant catalyst in the company's development. BEAT with an $82 market cap, operates in the specialty health services industry. People with heart conditions known as arrhythmias need to wear a monitor which translates via information to physicians via wireless sensors any irregularities that would require attention and possibly emergency services. CardioNet has been at the same thing since 2002 when it received FDA approval for its core technology. The company has grown from 3000 initial adopters to over 500,000 users today on a national scale.

While BEAT did receive a national reimbursement code in 2010, which was obviously crucial...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details